Predictors of embolization during protected renal artery angioplasty and stenting: Role of antiplatelet therapy

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 1, 2010, Pages 16-23

  Kanjwal, Khalil ^a   Cooper, Christopher J ^a   Virmani, Renu ^b   Haller, Steven ^a   Shapiro, Joseph I ^a   Burket, Mark W ^a   Steffes, Michael ^c   Brewster, Pamela ^a   Zhang, Haifeng ^a   Colyer Jr , William R ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b CVPATH INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Kidney; Peripheral vascular disease; Platelets; Stenosis; Stents

Indexed keywords

ABCIXIMAB; THIENOPYRIDINE DERIVATIVE; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CREATININE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; PYRIDINE DERIVATIVE;

AGED; ARTICLE; CAROTID ANGIOPLASTY; CAROTID ARTERY STENTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ARTERY EMBOLIZATION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; RANDOMIZED CONTROLLED TRIAL; ANGIOPLASTY; BLOOD; CHI SQUARE DISTRIBUTION; DEVICES; DRUG COMBINATION; DRUG EFFECTS; EMBOLISM; FEMALE; FILTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; RENAL ARTERY OBSTRUCTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STENT; TIME; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CREATININE; DRUG THERAPY, COMBINATION; EMBOLISM; FEMALE; FILTRATION; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PYRIDINES; RENAL ARTERY OBSTRUCTION; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77954274775     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22469     Document Type: Article

References (37)

1. Iannone LA, Underwood PL, Nath A, Tannenbaum MA, Ghali MG, Clevenger LD. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn 1996;37:243-250. (Pubitemid 126479790)
2. Henry M, Klonaris C, Henry I, Tzetanov K, Le Borgne E, Foliguet B, Hugel ML. Protected renal stenting with the PercuSurge GuardWire device: A pilot study. J Endovasc Ther 2001;8:227-237.
3. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: Early experience. J Vasc Surg 2003;38:962-968. (Pubitemid 37409629)
4. Edwards MS, Craven BL, Stafford J, Craven TE, Sauve KJ, Ayerdi J, Geary RL, Hansen KJ. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg 2006;44:128-135. (Pubitemid 43975288)
5. ASTRAL Investigators, Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J. Revascularization versus medical therapy for renal artery stenosis. The Astral Investigators. N Engl J Med 2009;361:1953-1962.
6. Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B, Huysmans FT, Schultze Kool LJ, Rutten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ, Plouin PF, Raynaud A, van Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: A randomized trial. Ann Intern Med 2009;150(12):840-848, W150-W151.
7. Henry M, Henry I, Klonaris C, Polydorou A, Rath P, Lakshmi G, Rajagopal S, Hugel M. Renal angioplasty and stenting under protection: The way for the future? Catheter Cardiovasc Interv 2003;60:299-312.
8. Henry M, Henry I, Polydorou A, Polydorou A, Hugel M. Endovascular treatment of a renal artery stenosis: Techniques, indications, results. Role of embolic protection devices (part 1). Angiol Sosud Khir 2007;13:33-40.
9. Henry M, Henry I, Polydorou A, Polydorou AD, Hugel M. Recent advances in renal artery stenting. J Cardiovasc Surg (Torino) 2007;48:411-442. (Pubitemid 350063596)
10. Henry M, Henry I, Polydorou A, Rajagopal S, Lakshmi G, Hugel M. Renal angioplasty and stenting: Long-term results and the potential role of protection devices. Expert Rev Cardiovasc Ther 2005;3:321-334. (Pubitemid 40424950)
11. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290. (Pubitemid 34260417)
12. Limbruno U, Micheli A, De Carlo M, Amoroso G, Rossini R, Palagi C, Di Bello V, Petronio AS, Fontanini G, Mariani M. Mechanical prevention of distal embolization during primary angioplasty: Safety, feasibility, and impact on myocardial reperfusion. Circulation 2003;108:171-176. (Pubitemid 36871299)
13. Izgi A, Kirma C, Tanalp AC, Dundar C, Oduncu V, Aung SM, Sonmez K, Mutlu B, Mansuroglu D. Predictors and clinical significance of angiographically detected distal embolization after primary percutaneous coronary interventions. Coron Artery Dis 2007;18:443-449. (Pubitemid 47262965)
14. Rapp JH, Pan XM, Sharp FR, Shah DM, Wille GA, Velez PM, Troyer A, Higashida RT, Saloner D. Atheroemboli to the brain: Size threshold for causing acute neuronal cell death. J Vasc Surg 2000;32:68-76.
15. Rapp JH, Pan XM, Yu B, Swanson RA, Higashida RT, Simpson P, Saloner D. Cerebral ischemia and infarction from atheroemboli <100 microm in size. Stroke 2003;34:1976-1980.
16. Jordan WD Jr., Voellinger DC, Doblar DD, Plyushcheva NP, Fisher WS, McDowell HA. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc Surg 1999;7:33-38.
17. Fasseas P, Orford JL, Denktas AE, Berger PB. Distal protection devices during percutaneous coronary and carotid interventions. Curr Control Trials Cardiovasc Med 2001;2:286-291.
18. Henry M, Henry I, Klonaris C, Masson I, Hugel M, Tzvetanov K, Ethevenot G, Le BE, Kownator S, Luizi F, Folliguet B. Benefits of cerebral protection during carotid stenting with the PercuSurge GuardWire system: midterm results. J Endovasc Ther 2002;9:1-13.
19. Henry M, Polydorou A, Klonaris C, Henry I, Polydorou AD, Hugel M. Carotid angioplasty and stenting under protection. State of the art. Minerva Cardioangiol 2007;55:19-56.
20. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-1705.
21. Kondo M, Nakano A, Saito D, Shimono Y. Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. J Am Coll Cardiol 1998;32:898-903.
22. Moses JW, Moussa I, Popma JJ, Sketch MH Jr., Yeh W. Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. Catheter Cardiovasc Interv 1999;47:149-154. (Pubitemid 29309529)
23. Trono R, Sutton C, Hollman J, Suit P, Ratliff NB. Mutiple myocardial infarction associated with atheromatous emboli after PTCA of saphenous vein graft. A clinicopathologic correlation. Cleveland Clin J Med 1989;66:581-584. (Pubitemid 20125581)
24. EPILOG Investigators., Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696. (Pubitemid 27251782)
25. Mueller C, Roskamm H, Neumann FJ, Hunziker P, Marsch S, Perruchoud A, Buettner HJ. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. J Am Coll Cardiol 2003;41:969-973. (Pubitemid 36315539)
26. Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents. Am Heart J 2000;140:483.
27. Cooper CJ, Haller ST, Colyer W, Steffes M, Burket MW, Thomas WJ, Safian R, Reddy B, Brewster P, Ankenbrandt MA, Virmani R, Dippel E, Rocha-Singh K, Murphy TP, Kennedy DJ, Shapiro JI, D'Agostino RD, Pencina MJ, Khuder S. Embolic protection and platelet inhibition during renal artery stenting. Circulation 2008;117:2752-2760.
28. Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH. Atheroemboli during renal artery angioplasty: An ex vivo study. J Vasc Surg 2005;41:1026-1030. (Pubitemid 40813034)
29. Edwards MS, Corriere MA, Craven TE, Pan XM, Rapp JH, Pearce JD, Mertaugh NB, Hansen KJ. Atheroembolism during percutaneous renal artery revascularization. J Vasc Surg 2007;46:55-61. (Pubitemid 46990762)
30. Hagspiel KD, Stone JR, Leung DA. Renal angioplasty and stent placement with distal protection: Preliminary experience with the FilterWire. EX. J Vasc Interv Radiol 2005;16:125-131.
31. Kawarada O, Yokoi Y, Takemoto K. The characteristics of dissemination of embolic materials during renal artery stenting. Catheter Cardiovasc Interv 2007;70:789-790.
32. Henry M, Amor M, Henry I, Klonaris C, Chati Z, Masson I, Kownator S, Luizy F, Hugel M. Carotid stenting with cerebral protection: First clinical experience using the PercuSurge GuardWire system. J Endovasc Surg 1999;6:321-331. (Pubitemid 30421301)
33. Angioplasty and stenting of the cervical carotid artery with distal embolic protection of the cerebral circulation. Technol Eval Cent Asses Program Exec Summ 2005 Feb; 19(15):1-4. PMID: 15714698.
34. Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K, He T. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-647. (Pubitemid 28387490)
35. Kennedy D, Colyer W, Brewster P, Ankenbrandt MA, Burket, M, Nemeth, A, Khuder S, Thomas W, Shapiro J, Cooper C. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis 2003;42:926-935.
36. Anderson HV, McNatt J, Clubb FJ, Herman M, Maffrand JP, DeClerck F, Ahn C, Buja LM, Willerson JT. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries. Circulation 2001;104:2331-2337.
37. Stys T, Lawson WE, Liuzzo JP, Hanif B, Bragg L, Cohn PF. Direct coronary stenting without balloon or device pretreatment: Acute success and long-term results. Catheter Cardiovasc Interv 2001;54:158-163.